Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses

Second response from Hawk on Feb. licenses

posted on Apr 30, 2008 04:59AM

I will continue to update as responses are received.

From Hawk,

Forwarding your email to the company.
Regards,
Ken AuYeung, Hawk Associates Inc.


Sent: Tue 4/29/2008 10:43 PM
To: Investor Relations
Subject: RE: 3rd Quarter Q

Ken:

What you sent to me is already known. It has been sent to many shareholders with the same explanation.

Please forward to someone at the company for me and ask the question of them as I have put it to you.

We as shareholders/owners deserve at least that much info esp. since it should not violate any agreement or NDA as long as no names or dollar

figures are used.

Possibly the CEO or CFO could respond to this question. If you feel you cannot do this for any reason let me know and I will ask them directly.

Share
New Message
Please login to post a reply